Avalyn Pharma Inc. — Investor Relations & Filings
Filings indexed
15
across all filing types
Latest filing
2026-05-09
Major Shareholding Noti…
Country
US
United States of America
Listing
—
AVLN
Avalyn Pharma Inc. is a clinical-stage biopharmaceutical company focused on developing innovative inhaled therapies for rare respiratory diseases. The company's primary focus is on pulmonary fibrosis, including Idiopathic Pulmonary Fibrosis, and other interstitial lung diseases, where there is a significant unmet medical need. Avalyn's approach involves creating new inhaled formulations of approved medicines, utilizing a nebulization method designed to directly target the lung. This strategy aims to improve the substantial tolerability issues often associated with existing oral treatment options, thereby enhancing patient outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2026 | 2026-05-09 | English | |
| Major Shareholding Notification 2026 | 2026-05-08 | English | |
| Major Shareholding Notification 2026 | 2026-05-07 | English | |
| Major Shareholding Notification 2026 | 2026-05-05 | English | |
| 8-K | 2026-05-01 | English | |
| S-8 | 2026-04-30 | English |
Browse filings by year
1 year| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46722384 | Major Shareholding Notification 2026 | 2026-05-09 | English | ||
| 46722385 | Major Shareholding Notification 2026 | 2026-05-08 | English | ||
| 46722389 | Major Shareholding Notification 2026 | 2026-05-07 | English | ||
| 46722386 | Major Shareholding Notification 2026 | 2026-05-05 | English | ||
| 46722393 | 8-K | 2026-05-01 | English | ||
| 46722402 | S-8 | 2026-04-30 | English | ||
| 46722419 | 424B4 | 2026-04-30 | English | ||
| 46722420 | Regulatory Filings 2026 | 2026-04-30 | English | ||
| 46722422 | Regulatory Filings 2026 | 2026-04-29 | English | ||
| 46722452 | S-1/A | 2026-04-29 | English | ||
| 46722454 | 8-A12B | 2026-04-27 | English | ||
| 46722465 | S-1/A | 2026-04-23 | English | ||
| 46722470 | S-1 | 2026-04-08 | English | ||
| 46722476 | Regulatory Filings 2026 | 2026-03-18 | English | ||
| 46722488 | Regulatory Filings 2026 | 2026-02-06 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Boji Medical Technology Co., Ltd.
A CRO providing full-service pharmaceutical and medical dev…
|
300404 | CN | Professional, scientific and te… |
|
Bonus BioGroup Ltd.
A clinical-stage biotech firm developing cell therapy and t…
|
BONS | IL | Professional, scientific and te… |
|
BPH GLOBAL LTD
Biotech firm focused on plant-based health products and fun…
|
BP8 | AU | Professional, scientific and te… |
|
BRAIN Biotech AG
Develops enzymes and microorganisms for the food, chemical,…
|
BNN | DE | Professional, scientific and te… |
|
BriaCell Therapeutics Corp.
Clinical-stage immuno-oncology company developing cellular …
|
BCTX | CA | Professional, scientific and te… |
|
Bright Minds Biosciences Inc.
Developing innovative serotonin-based drugs for neurologica…
|
DRUG | CA | Professional, scientific and te… |
|
BRIM
Develops therapies for ophthalmology and degenerative disea…
|
6885 | TW | Professional, scientific and te… |
|
BSF ENTERPRISE PLC
Develops cell-based solutions for cultivated meat, leather,…
|
BSFA | GB | Professional, scientific and te… |
|
BullFrog AI Holdings, Inc.
A technology company applying AI and machine learning to dr…
|
BFRG | US | Professional, scientific and te… |
|
Burning Rock Biotech Ltd
A global diagnostics company specializing in precision onco…
|
BNR | US | Professional, scientific and te… |
Avalyn Pharma Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/72583/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=72583 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=72583 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=72583 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 72583}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Avalyn Pharma Inc. (id: 72583)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.